Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development

Por Axten, Jeffrey M., Romeril, Stuart P., Shu, Arthur, Ralph, Jeffrey, Medina, Jesús R., Feng, Yanhong, Li, William Hoi Hong, Grant, Seth W., Heerding, Dirk A., Minthorn, Elisabeth, Mencken, Thomas, Gaul, Nathan, Goetz, Aaron, Stanley, Thomas, Hassell, Annie M., Gampe, Robert T., Atkins, Charity, Kumar, Rakesh
Publicado em 2013

Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2

Por Verma, Sharad K., Tian, Xinrong, LaFrance, Louis V., Duquenne, Céline, Suarez, Dominic P., Newlander, Kenneth A., Romeril, Stuart P., Burgess, Joelle L., Grant, Seth W., Brackley, James A., Graves, Alan P., Scherzer, Daryl A., Shu, Art, Thompson, Christine, Ott, Heidi M., Aller, Glenn S. Van, Machutta, Carl A., Diaz, Elsie, Jiang, Yong, Johnson, Neil W., Knight, Steven D., Kruger, Ryan G., McCabe, Michael T., Dhanak, Dashyant, Tummino, Peter J., Creasy, Caretha L., Miller, William H.
Publicado em 2012